Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
04/2010
04/14/2010EP1335901B1 Pharmaceutically active sulfanilide derivatives
04/14/2010EP0831903B1 Connective tissue growth factor
04/14/2010CN1994277B Solid preparation of salvianolic acid A of red sage root and preparation process thereof
04/14/2010CN1974594B Human myocardial troponin I subunit nucleic acid adaptor and its application
04/14/2010CN1935230B Chinese medicine injection preparation and its preparing method
04/14/2010CN1931236B Medicine composition of red sage and rhodiola root
04/14/2010CN1931218B Medicine composition of ligustrazine and rhodiola root
04/14/2010CN1907357B Compound recipe pollen extract oral liquid for regulating blood pressure and blood fat, and process for preparing same
04/14/2010CN1899357B Method for producing persimmon frost medicine
04/14/2010CN1872319B Application of medication composition of containing polygala root in preparing medicine for treating insufficiency of blood supply for brain
04/14/2010CN1853674B Quality controlling method of Xingdan injection
04/14/2010CN1847260B Wheat germ protein depressor peptide desalting process
04/14/2010CN101693718A Ester derivative containing thienopyridine and preparation method and application thereof
04/14/2010CN101693099A Traditional Chinese medicine composite for treating tachyrhythmia
04/14/2010CN101693078A Traditional Chinese medicine for treating heart disease
04/14/2010CN101693068A Medicament for lowering blood pressure and blood lipid
04/14/2010CN101693066A Traditional Chinese medicine for treating cardiac infarction
04/14/2010CN101693062A Health-care product for reducing pressure and sugar and eliminating fat
04/14/2010CN101693053A Traditional Chinese medicine for treating cerebral infarction
04/14/2010CN101693046A Chinese medicine composition capable of improving anoxia endurance
04/14/2010CN101693045A Effective portion of conical hydrangea, preparation method thereof, and composition and usage thereof
04/14/2010CN101693025A Application of anti-atherosclerotic thrombotic compounds in preparing medicine for treating vascular disfunction
04/14/2010CN101185619B Hemorrhoid-eliminating shower cream and preparation method
04/14/2010CN101152458B Traditional Chinese medicine preparation for treating cerebral apoplexy sequela
04/14/2010CN101152223B Use of poplar leaf phenols extract in preparation of medicine for treating cardiovascular disease
04/14/2010CN101129353B Use of 7-hydroxyl-3-[(4-hydroxyl)-3-(3-methyl- butyl-2- alkenyl) phenyl]-4H-1-benzopyran-4-ket
04/14/2010CN101023978B Zhiloukang medicine for treating hemorrhoids and fistula
04/14/2010CN101019878B Injection medicine composite containing salvianolic acid A and its preparation
04/13/2010USRE41226 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
04/13/2010US7696365 Heterocyclic compounds useful as malonyl-CoA decarboxylase inhibitors
04/13/2010US7696247 Lipid-based nitric oxide donors
04/13/2010US7696206 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
04/13/2010US7696181 Partial and full agonists of A1 adenosine receptors
04/13/2010US7696177 N-[3-(4-{(2S,3R)-2-(-(4-{[(2S, 5S, 3R, 4R, 6R)-3,4,5-trihydroxy-6-(hydroxymethyl)perhydro-2H-pyran-2-yl]ethyl-2-yl}phenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxoazetidin-1-yl}phenyl)propyl]-N-methylmethanesulfonamide; anticholesterol agent; low density lipoprotein; treating atherosclerosis
04/13/2010US7696172 culture product produced by culturing a recombinant host cell under suitable conditions to express the polypeptide; has an oncogenic activity; treating liver disorder cirrhosis, or pancreas disorder
04/13/2010US7696157 Plurality of isolated erythropoietin-like molecules; reperfusion injuries; antiischemic, antihypoxic, antiinflammatory gents; neurodegenerative or nervous system disorders; genetic engineering and expression
04/13/2010US7696156 Human hemojuvelin (HJV) or dragon-like 1 (DL-1) polypeptides and variants and uses thereof
04/13/2010US7696155 Hemojuvelin or dragon-like 2 (DL-2) polypeptides and variants and uses thereof
04/13/2010US7696151 Providing a screening assay having stearoyl-CoA desaturase biological activity, contacting sceening assay with a test compound and measuring the biological activity
04/13/2010US7695731 Drug delivery; vascular disease; stents, grafts, anastomotic devices, perivascular wraps, sutures and staples
04/13/2010US7695720 target VEGFR2 (KDR/flk-1); for treating and preventing tumors
04/13/2010CA2537404C Crystalline .gamma.-d form of ivabradine hydrochloride, the process for preparing it, and the pharmaceutical compositions that contain it
04/13/2010CA2443802C Pyrazolo[1,5-a]pyridines and medicines containing the same
04/13/2010CA2436220C New mandelic acid derivatives and their use as thrombin inhibitors
04/13/2010CA2432303C Pyrazole compounds useful as protein kinase inhibitors
04/13/2010CA2432150C Glycosaminoglycans derived from k5 polysaccharide having high antithrombin activity and process for their preparation
04/13/2010CA2431308C Regulation of angiogenesis with zinc finger proteins
04/13/2010CA2430363C Compounds and their uses
04/13/2010CA2422377C Pyrazole compounds useful as protein kinase inhibitors
04/13/2010CA2394165C Drospirenone for hormone replacement therapy
04/13/2010CA2392016C Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
04/13/2010CA2360680C Antioxidant compositions and methods for companion animals
04/13/2010CA2336807C Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
04/13/2010CA2295678C Pyridine derivatives
04/08/2010WO2010040110A1 Methods and compositions for treatment of acute heart failure
04/08/2010WO2010040054A2 Methods for suppressing toll-like receptor activity
04/08/2010WO2010039977A2 Heteroaryl antagonists of prostaglandin d2 receptors
04/08/2010WO2010039719A1 Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
04/08/2010WO2010039697A2 Selective inhibition of histone deacetylases 1 and 2 as a treatment for cardiac hypertrophy
04/08/2010WO2010038901A1 7-piperidinoalkyl-3,4-dihydroquinolone derivative
04/08/2010WO2010038689A1 Pharmaceutical composition for oral administration
04/08/2010WO2010038465A1 8-substituted isoquinoline derivative and use thereof
04/08/2010WO2010037856A2 DYNACTIN-1/p150glued AS A TARGET FOR TUMOR DIAGNOSIS AND THERAPY AND A METHOD FOR IDENTIFYING TARGETABLE DISEASE-RELATED PROTEINS
04/08/2010WO2010037269A1 The use of hirsutine in preparation of medicaments for treating myocardial damage
04/08/2010WO2010037224A1 Method for preventing and treating cardiovascular diseases with brca1
04/08/2010WO2009156092A3 Bi-and polycyclic substituted isoquinoline and isoquinoline derivatives as rho kinase inhibitors
04/08/2010WO2009149161A9 Chimeric natriuretic polypeptides and methods for inhibiting cardiac remodeling
04/08/2010WO2009149148A9 Long-acting glp-1 derivatives, and methods of treating cardiac dysfunction
04/08/2010WO2009018662A9 Renin inhibitors
04/08/2010US20100087651 New mandelic acid derivatives and their use as thrombin inhibitors
04/08/2010US20100087547 Use of a Blood-Flow Decrease Preventing Agent in Conjunction With Insufflating Gas
04/08/2010US20100087544 N, n -dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
04/08/2010US20100087536 Amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof
04/08/2010US20100087502 Indazoles Used To Treat Estrogen Receptor Beta Mediated Disorders
04/08/2010US20100087501 Highly Bioavailable Composition Containing Eprosartan-Poloxamer Complex or 2-(7-Chloro-5-Methyl-4-Oxo-3-Phenyl-4,5-Dihydro-3H-Pyridazine (4,5-b)Indol-1-yl)-N,N-Dimethylacetamide - Poloxamer Complex
04/08/2010US20100087500 Methods and Compositions for Treatment of Acute Heart Failure
04/08/2010US20100087488 Physiologically Acceptable Salts of 3-[(2--1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester
04/08/2010US20100087462 Methods for predicting and detecting intolerance to an hypolipidemic agent
04/08/2010US20100087438 New Potassium Channel Blockers
04/08/2010US20100087367 Products and methods using soy peptides to lower total and ldl cholesterol levels
04/08/2010US20100087363 Glycan modified soluble receptors and binding protein and their use
04/08/2010US20100087362 Use of biglycan or enhancers of biglycan activity in the preparation of pharmaceutical compositions
04/08/2010US20100087359 Use of tryptophan rich peptides
04/08/2010US20100086602 Pharmaceutical composition containing statin-encapsulated nanoparticle
04/08/2010US20100086590 Novel stable pharmaceutical compositions of clopidogrel bisulfate and process of preparation thereof
04/08/2010US20100086586 Pharmaceutical Composition
04/08/2010US20100086542 Potentiation of erythropoietin (epo) action by membrane steroid receptor agonists
04/08/2010CA2739513A1 7-piperidinoalkyl-3,4-dihydroquinolone derivative
04/08/2010CA2739463A1 Methods and compositions for treatment of acute heart failure
04/08/2010CA2739083A1 Methods for suppressing toll-like receptor activity
04/08/2010CA2738912A1 Pharmaceutical composition for oral administration
04/08/2010CA2738563A1 8-substituted isoquinoline derivatives and the use thereof
04/08/2010CA2736102A1 Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
04/07/2010EP2172560A2 stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
04/07/2010EP2172472A2 Aminophosphonic acid derivative, salt thereof and modulator of S1P receptor
04/07/2010EP2172468A1 Benzimidazolone compounds
04/07/2010EP2172458A1 Pyrazolone derivative
04/07/2010EP2172453A1 COMPOUND HAVING 11 ß-HSD1 INHIBITORY ACTIVITY
04/07/2010EP2172226A1 Method of fixing and expressing physiologically active substance
04/07/2010EP2172225A1 Sealmess capsule
1 ... 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 ... 1595